- Home
- Publications
- Publication Search
- Publication Details
Title
Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates
Authors
Keywords
Osteoporosis, Anti-resorptives, Anabolics, DXA, Biochemical markers of bone turnover
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 103, Issue 1, Pages 55-61
Publisher
Springer Nature
Online
2018-02-14
DOI
10.1007/s00223-018-0404-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation
- (2017) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures
- (2017) T. Lehmann et al. OSTEOPOROSIS INTERNATIONAL
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports
- (2015) B. Aubry-Rozier et al. OSTEOPOROSIS INTERNATIONAL
- Multiple clinical vertebral fractures following denosumab discontinuation
- (2015) A. D. Anastasilakis et al. OSTEOPOROSIS INTERNATIONAL
- Rebound-associated vertebral fractures after discontinuation of denosumab—from clinic and biomechanics
- (2015) A. W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now